Diabetes vaccine stumbles at second hurdle
An experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process, doctors said on Monday in a study reported online by The Lancet.
An experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process, doctors said on Monday in a study reported online by The Lancet.
Tobacco isn't famous for its health benefits. But now scientists have succeeded in using genetically modified tobacco plants to produce medicines for several autoimmune and inflammatory diseases, including diabetes. The research ...